Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_48043 | 1751 | 36.48 | Mlig455_017279, Mlig455_017291 | Neo: - Age: - Region-enriched R7: 2.553/0.00000 Regeneration-downregulated BL: -2.231 Regeneration-depleted BL: -2.231 |
Mlig455_017279 {REF} {Length: 4223} {RNA1509_52225} {RNA1310_3440.1} {RNA815_638.1} Mlig455_017291 {REF} {Length: 3855} {RNA1509_3814, RNA1509_50356} {RNA1310_3440.1, RNA1509_50356} {RNA1509_50356, RNA815_638.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.742 | 5.357 | 0.34458 | 0.98843 | |
RegionR2 | -0.204 | 5.357 | 0.65691 | 0.98987 | |
RegionR3 | -0.257 | 5.357 | 0.51176 | 0.99996 | |
RegionR4 | -1.604 | 5.357 | 0.00110 | 0.01122 | |
RegionR5 | -2.294 | 5.357 | 0.00000 | 0.00001 | |
RegionR6 | 0.507 | 5.357 | 0.17095 | 0.72828 | |
RegionR7 | 2.553 | 5.357 | 0.00000 | 0.00000 | |
RegionR8 | 0.558 | 5.357 | 0.26870 | 0.89179 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.628 | 5.357 | 0.16418 | 0.90650 | |
RegenerationR2 | 0.277 | 5.357 | 0.54381 | 0.88990 | |
RegenerationR3 | 0.649 | 5.357 | 0.17705 | 0.61232 | |
RegenerationR4 | 0.436 | 5.357 | 0.39754 | 0.81179 | |
RegenerationR5 | 0.565 | 5.357 | 0.26653 | 0.69779 | |
RegenerationR6 | -0.444 | 5.357 | 0.35298 | 0.69820 | |
RegenerationBL | -2.231 | 5.357 | 0.00003 | 0.00194 | Specific for BL: -2.231 |
RegenerationTP | -0.767 | 5.357 | 0.12290 | 0.53163 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_48043 | 1751 | 36.48 | Mlig455_017279, Mlig455_017291 | Neo: - Age: - Region-enriched R7: 2.553/0.00000 Regeneration-downregulated BL: -2.231 Regeneration-depleted BL: -2.231 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_017279 {REF} {Length: 4223} {RNA1509_52225} {RNA1310_3440.1} {RNA815_638.1} Mlig455_017291 {REF} {Length: 3855} {RNA1509_3814, RNA1509_50356} {RNA1310_3440.1, RNA1509_50356} {RNA1509_50356, RNA815_638.1} |
|
2. | MligTC455_45836 | 5904 | 123 | Mlig455_056773 | Neo: - Age: - Region-enriched R7: 2.597/0.00000 Regeneration-downregulated BL: -2.420 Regeneration-depleted BL: -2.420 |
CD63 | 3.445 | 0.794 | 0.891 | - | 0.801 | - | 0.959 | Mlig455_056773 {REF} {Length: 1763} {Pfam: Tetraspanin family [PF00335.22, score=136.4]} {Human: ENSG00000135404, CD63, CD63 molecule, [Score=77.8, Expect=3e-16]} {Mouse: ENSMUSG00000030342, Cd9, CD9 antigen, [Score=70.9, Expect=5e-14]; ENSMUSG00000027215, Cd82, CD82 antigen, [Score=70.5, Expect=1e-13]; ENSMUSG00000025351, Cd63, CD63 antigen, [Score=70.5, Expect=7e-14]; ENSMUSG00000027858, Tspan2, tetraspanin 2, [Score=68.6, Expect=4e-13]; ENSMUSG00000001763, Tspan33, tetraspanin 33, [Score=67.8, Expect=1e-12]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [RH, Score=109, Expect=6e-28]} {Celegans: WBGene00006635, tsp-9, Tetraspanin, [Score=60.5, Expect=2e-10]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [Score=145, Expect=1e-41]} {RNA1509_12921, RNA1509_17467, RNA1509_2902, RNA1509_29605, RNA1509_30887, RNA1509_38875, RNA1509_50949, RNA1509_53162} {RNA1310_5555, RNA1509_12921, RNA1509_17467, RNA1509_2902, RNA1509_29605, RNA1509_30887, RNA1509_38875, RNA1509_50949, RNA1509_53162} {RNA1509_12921, RNA1509_17467, RNA1509_2902, RNA1509_29605, RNA1509_30887, RNA1509_38875, RNA1509_50949, RNA1509_53162, RNA815_1574.1} |
3. | MligTC455_35188 | 340 | 7.08 | Mlig455_017705, Mlig455_017757 | Neo: - Age: - Region-enriched R7: 4.175/0.00000 |
PLEKHB1 | 2.701 | - | 0.951 | - | 0.841 | - | 0.909 | Mlig455_017705 {REF} {Length: 1121} {Pfam: PH domain [PF00169.31, score=38.5]} {Human: ENSG00000021300, PLEKHB1, pleckstrin homology domain containing B1, [RH, Score=76.6, Expect=1e-16]; ENSG00000115762, PLEKHB2, pleckstrin homology domain containing B2, [RH, Score=75.5, Expect=3e-16]} {Mouse: ENSMUSG00000030701, Plekhb1, pleckstrin homology domain containing, family B (evectins) member 1, [RH, Score=79.7, Expect=5e-18]; ENSMUSG00000026123, Plekhb2, pleckstrin homology domain containing, family B (evectins) member 2, [RH, Score=78.2, Expect=2e-17]} {Smed: dd_Smed_v6_1927_0_1, dd_Smed_v6_1927_0_1, [RH, Score=124, Expect=4e-35]} {RNA1509_56045} {RNA1310_40666.2} {RNA815_39297} Mlig455_017757 {REF} {Length: 1030} {Pfam: PH domain [PF00169.31, score=38.5]} {Human: ENSG00000021300, PLEKHB1, pleckstrin homology domain containing B1, [RH, Score=76.6, Expect=1e-16]; ENSG00000115762, PLEKHB2, pleckstrin homology domain containing B2, [RH, Score=75.5, Expect=3e-16]} {Mouse: ENSMUSG00000030701, Plekhb1, pleckstrin homology domain containing, family B (evectins) member 1, [RH, Score=79.7, Expect=5e-18]; ENSMUSG00000026123, Plekhb2, pleckstrin homology domain containing, family B (evectins) member 2, [RH, Score=78.2, Expect=2e-17]} {Smed: dd_Smed_v6_1927_0_1, dd_Smed_v6_1927_0_1, [RH, Score=124, Expect=4e-35]} {RNA1509_56045} {RNA1310_40666.2, RNA1509_56045} {RNA1509_56045, RNA815_39297} |
4. | MligTC455_25181 | 2947 | 61.4 | Mlig455_016583, Mlig455_016639, Mlig455_035594, Mlig455_035605, Mlig455_051883 | Neo: - Age: logFC(26M/2M)=-0.369 Region-enriched R7: 3.379/0.00000 Regeneration-downregulated BL: -3.511 Regeneration-depleted BL: -3.511 |
2.675 | 0.784 | 0.939 | - | - | - | 0.952 | Mlig455_016583 {REF} {Length: 2083} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=45.3]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=82.4, Expect=1e-18]} {RNA1509_22294} {RNA1310_28969} {RNA815_14223} Mlig455_016639 {REF} {Length: 2081} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=20.8]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=63.5, Expect=2e-12]} {RNA1509_22294} {RNA1310_28969} {RNA815_14223} Mlig455_035594 {REF} {Length: 986} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=46.3]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=82.8, Expect=3e-19]} {RNA1509_50243} {RNA1310_28969} {RNA815_14223} Mlig455_035605 {REF} {Length: 2250} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=46.3]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=82.0, Expect=6e-19]} {RNA1509_58072} {RNA1310_28969} {RNA815_14223} Mlig455_051883 {REF} {Length: 914} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=45.3]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=82.4, Expect=1e-18]} {RNA1509_50243} {RNA1310_28969} {RNA815_14223} |
|
5. | MligTC455_48311 | 3195 | 66.57 | Mlig455_007190, Mlig455_007200, Mlig455_007260 | Neo: - Age: logFC(26M/2M)=-0.211 Region-enriched R7: 3.482/0.00000 Regeneration-downregulated BL: -3.047 Regeneration-depleted BL: -3.047 |
SVOP | 2.626 | 0.736 | 0.955 | - | - | - | 0.935 | Mlig455_007190 {REF} {Length: 2867} {Pfam: Sugar (and other) transporter [PF00083.26, score=120.5]; Major Facilitator Superfamily [PF07690.18, score=78.0]; MFS_1 like family [PF12832.9, score=25.1]} {Human: ENSG00000166111, SVOP, SV2 related protein, [Score=286, Expect=5e-90]} {Mouse: ENSMUSG00000042078, Svop, SV2 related protein, [Score=280, Expect=9e-88]} {Dmel: FBgn0034956, CG4324, [Score=239, Expect=3e-73]} {Celegans: WBGene00014021, svop-1, Putative transporter svop-1, [Score=268, Expect=8e-84]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [Score=294, Expect=2e-94]} {RNA1509_40948} {RNA1310_7004.1} {RNA815_5149} Mlig455_007200 {REF} {Length: 2805} {Pfam: Major Facilitator Superfamily [PF07690.18, score=39.9]; Sugar (and other) transporter [PF00083.26, score=32.1]} {Human: ENSG00000166111, SVOP, SV2 related protein, [Score=140, Expect=4e-37]} {Mouse: ENSMUSG00000042078, Svop, SV2 related protein, [Score=144, Expect=2e-38]} {Dmel: FBgn0034956, CG4324, [Score=103, Expect=2e-24]} {Celegans: WBGene00014021, svop-1, Putative transporter svop-1, [Score=131, Expect=4e-34]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [Score=150, Expect=2e-41]} {RNA1509_56107} {RNA1310_7004.1} {RNA815_11918} Mlig455_007260 {REF} {Length: 2807} {Pfam: Sugar (and other) transporter [PF00083.26, score=117.7]; Major Facilitator Superfamily [PF07690.18, score=102.3]} {Human: ENSG00000166111, SVOP, SV2 related protein, [Score=311, Expect=2e-99]} {Mouse: ENSMUSG00000042078, Svop, SV2 related protein, [Score=306, Expect=2e-97]} {Dmel: FBgn0034956, CG4324, [Score=254, Expect=1e-78]} {Celegans: WBGene00014021, svop-1, Putative transporter svop-1, [Score=298, Expect=4e-95]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [Score=321, Expect=3e-104]} {RNA1509_34029, RNA1509_40948, RNA1509_56107} {RNA1310_7004.1, RNA1509_34029, RNA1509_40948, RNA1509_56107} {RNA1509_34029, RNA1509_40948, RNA1509_56107, RNA815_11918} |
6. | MligTC455_32784 | 1194 | 24.87 | Mlig455_043430 | Neo: - Age: - Region-enriched R7: 1.555/0.01708 |
RCL1 | 2.562 | - | 0.764 | - | - | 0.832 | 0.966 | Mlig455_043430 {REF} {Length: 3933} {TRANSSPLICED} {Pfam: RNA 3'-terminal phosphate cyclase [PF01137.23, score=175.4]; Cyclic nucleotide-binding domain [PF00027.31, score=133.6]; RNA 3'-terminal phosphate cyclase (RTC), insert domain [PF05189.15, score=90.1]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=44.2]} {Human: ENSG00000120158, RCL1, RNA terminal phosphate cyclase like 1, [RH, Score=358, Expect=1e-116]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [RH, Score=380, Expect=1e-124]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=385, Expect=3e-127]} {Celegans: WBGene00022852, ZK1127.5, Probable RNA 3'-terminal phosphate cyclase-like protein, [RH, Score=299, Expect=3e-94]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [Score=428, Expect=3e-144]} {RNA1509_16905} {RNA1310_10559.2} {RNA815_4244.1} |
7. | MligTC455_53644 | 184 | 3.84 | Mlig455_037750, Mlig455_069925 | Neo: - Age: Down-Up-Down Region-enriched R7: 3.882/0.00000 |
2.47 | 0.755 | - | - | - | 0.764 | 0.951 | Mlig455_037750 {REF} {Length: 1868} {RNA1509_19098} {RNA1310_52130} {RNA815_43313} Mlig455_069925 {REF} {Length: 1868} {RNA1509_19098} {RNA1310_52130} {RNA815_43313} |
|
8. | MligTC455_28462 | 236 | 4.91 | Mlig455_007790 | Neo: - Age: - |
2.469 | - | - | - | 0.767 | 0.950 | 0.752 | Mlig455_007790 {REF} {Length: 1924} {RNA1509_24727} {RNA1310_9330} {RNA815_6709} | |
9. | MligTC455_24113 | 417 | 8.68 | Mlig455_051239 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.866/0.00000 |
1.782 | - | 0.950 | - | - | - | 0.832 | Mlig455_051239 {REF} {Length: 4276} {NoTransDecoderORF} {RNA1509_23461} {RNA1310_60603} {RNA815_48925} | |
10. | MligTC455_18492 | 32 | 0.68 | Mlig455_026506 | Neo: - Age: - |
ADRA1B | 1.713 | - | - | - | - | 0.952 | 0.761 | Mlig455_026506 {REF} {Length: 1747} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=271.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=40.7]} {Human: ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=244, Expect=8e-74]} {Mouse: ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [Score=242, Expect=3e-73]} {Dmel: FBgn0266137, Dop1R2, Dopamine 1-like receptor 2, [RH, Score=310, Expect=2e-96]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=196, Expect=4e-57]} {Smed: dd_Smed_v6_22802_0_1, dd_Smed_v6_22802_0_1, [RH, Score=325, Expect=9e-107]} {RNA1310_108893} |
11. | MligTC455_41180 | 128 | 2.66 | Mlig455_048529 | Neo: - Age: - Region-enriched R2: 3.286/0.00629 |
0.986 | - | - | - | - | 0.986 | - | Mlig455_048529 {REF} {Length: 672} {NoTransDecoderORF} {RNA1310_69878} {RNA815_35715} | |
12. | MligTC455_05698 | 351 | 7.31 | Mlig455_020822 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.385 Regeneration-downregulated BL: -4.521 Regeneration-depleted BL: -4.521 |
CTSA | 0.977 | - | - | 0.977 | - | - | - | Mlig455_020822 {REF} {Length: 1852} {Pfam: Serine carboxypeptidase [PF00450.24, score=274.5]} {Human: ENSG00000064601, CTSA, cathepsin A, [Score=190, Expect=2e-54]} {Mouse: ENSMUSG00000017760, Ctsa, cathepsin A, [Score=158, Expect=2e-45]} {Dmel: FBgn0038738, CG4572, [Score=106, Expect=1e-24]} {Celegans: WBGene00019605, ctsa-1, Uncharacterized serine carboxypeptidase ctsa-1, [Score=194, Expect=1e-56]} {Smed: dd_Smed_v6_785_0_1, dd_Smed_v6_785_0_1, [Score=169, Expect=4e-47]} {RNA1509_18333, RNA1509_43429} {RNA1310_12718, RNA1509_18333, RNA1509_43429} {RNA1509_18333, RNA1509_43429, RNA815_3781} |
13. | MligTC455_24993 | 233 | 4.86 | Mlig455_050468 | Neo: - Age: Up-Down-Down |
PTPRS | 0.976 | - | - | - | - | 0.976 | - | Mlig455_050468 {REF} {Length: 2099} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=259.3]; Tyrosine phosphatase family [PF13350.8, score=26.7]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=20.1]} {Human: ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [Score=499, Expect=3e-164]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [Score=494, Expect=1e-163]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [Score=500, Expect=7e-167]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [Score=493, Expect=2e-162]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [Score=491, Expect=9e-163]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [Score=454, Expect=7e-146]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [Score=318, Expect=9e-100]} {Smed: dd_Smed_v6_9734_0_1, dd_Smed_v6_9734_0_1, [Score=439, Expect=8e-146]} {RNA1509_59220} {RNA1310_403.1} {RNA815_2245.3} |
14. | MligTC455_43925 | 14 | 0.28 | Mlig455_007983 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_007983 {REF} {Length: 2821} {RNA1310_91563} | |
15. | MligTC455_36254 | 3089 | 64.36 | Mlig455_001367 | Neo: - Age: - |
GPC4 | 0.971 | - | - | - | - | 0.971 | - | Mlig455_001367 {REF} {Length: 6001} {TRANSSPLICED} {Pfam: Glypican [PF01153.21, score=256.6]} {Human: ENSG00000076716, GPC4, glypican 4, [RH, Score=185, Expect=2e-49]; ENSG00000183098, GPC6, glypican 6, [RH, Score=180, Expect=1e-47]} {Mouse: ENSMUSG00000031119, Gpc4, glypican 4, [RH, Score=184, Expect=4e-49]; ENSMUSG00000058571, Gpc6, glypican 6, [RH, Score=181, Expect=5e-48]} {RNA1509_2649, RNA1509_46802, RNA1509_50600, RNA1509_6126} {RNA1310_2329, RNA1509_46802, RNA1509_50600, RNA1509_6126} {RNA1509_46802, RNA1509_50600, RNA1509_6126, RNA815_4068} |
16. | MligTC455_24992 | 222 | 4.62 | Mlig455_040423 | Neo: - Age: Up-Down-Down |
PTPRD | 0.97 | - | - | - | - | 0.970 | - | Mlig455_040423 {REF} {Length: 5511} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=536.0]; Fibronectin type III domain [PF00041.23, score=69.6]; Tyrosine phosphatase family [PF13350.8, score=37.9]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=33.7]; Inositol hexakisphosphate [PF14566.8, score=24.3]} {Human: ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [RH, Score=1010, Expect=0.0]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [RH, Score=1009, Expect=0.0]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [RH, Score=1023, Expect=0.0]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [RH, Score=1011, Expect=0.0]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [RH, Score=1004, Expect=0.0]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [RH, Score=928, Expect=0.0]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [RH, Score=723, Expect=0.0]} {Smed: dd_Smed_v6_10176_0_2, dd_Smed_v6_10176_0_2, [RH, Score=962, Expect=0.0]} {RNA1509_45823, RNA1509_59220} {RNA1310_2694.1, RNA1509_45823, RNA1509_59220} {RNA1509_45823, RNA1509_59220, RNA815_2245.1} |
17. | MligTC455_42700 | 851 | 17.73 | Mlig455_034472 | Neo: - Age: - Region-enriched R2: 1.255/0.04544 |
YWHAE | 0.969 | - | - | - | - | 0.969 | - | Mlig455_034472 {REF} {Length: 1614} {TRANSSPLICED} {Pfam: 14-3-3 protein [PF00244.22, score=258.7]} {Human: ENSG00000108953, YWHAE, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon, [Score=300, Expect=1e-103]; ENSG00000274474, YWHAE, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon, [Score=300, Expect=1e-103]} {Mouse: ENSMUSG00000020849, Ywhae, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide, [Score=300, Expect=1e-103]} {Dmel: FBgn0020238, 14-3-3epsilon, [Score=299, Expect=3e-103]} {Celegans: WBGene00001502, ftt-2, 14-3-3-like protein 2, [Score=236, Expect=8e-79]} {Smed: dd_Smed_v6_1702_0_1, dd_Smed_v6_1702_0_1, [Score=273, Expect=4e-93]} {RNA1509_35947, RNA1509_43335, RNA1509_50818} {RNA1310_15023.1, RNA1509_35947, RNA1509_50818} {RNA1509_35947, RNA1509_50818, RNA815_5579} |
18. | MligTC455_36374 | 58 | 1.2 | Mlig455_016115 | Neo: - Age: - |
0.968 | - | - | - | - | - | 0.968 | Mlig455_016115 {REF} {Length: 4900} {RNA1509_18263} {RNA1310_1232} {RNA815_347} | |
19. | MligTC455_48185 | 70 | 1.45 | Mlig455_035439 | Neo: - Age: - |
0.968 | - | - | - | - | - | 0.968 | Mlig455_035439 {REF} {Length: 2757} {RNA1310_13118.1} {RNA815_17949} | |
20. | MligTC455_42365 | 56 | 1.17 | Mlig455_037334 | Neo: - Age: - |
CHRNA3 | 0.967 | - | - | - | - | 0.967 | - | Mlig455_037334 {REF} {Length: 3103} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=226.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=224.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=376, Expect=9e-124]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=372, Expect=2e-122]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=360, Expect=9e-118]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=382, Expect=2e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=374, Expect=2e-123]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=451, Expect=2e-153]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=384, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [RH, Score=660, Expect=0.0]} {RNA1509_45903} {RNA1310_11151} {RNA815_10044.1} |
21. | MligTC455_13897 | 26 | 0.54 | Mlig455_007882 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_007882 {REF} {Length: 1288} {RNA1310_105239.2} {RNA815_16034.1} | |
22. | MligTC455_25378 | 134 | 2.8 | Mlig455_016116 | Neo: - Age: - Region-enriched R7: 3.311/0.00287 |
TNS2 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_016116 {REF} {Length: 2694} {Pfam: SH2 domain [PF00017.26, score=30.8]; Phosphotyrosine-binding domain [PF08416.15, score=22.5]} {Human: ENSG00000111077, TNS2, tensin 2, [Score=95.9, Expect=5e-20]} {Mouse: ENSMUSG00000037003, Tns2, tensin 2, [Score=90.1, Expect=2e-18]} {Smed: dd_Smed_v6_4454_0_2, dd_Smed_v6_4454_0_2, [Score=97.4, Expect=3e-21]} {RNA1509_44612} {RNA1310_9162.1} {RNA815_10953} |
23. | MligTC455_31074 | 50 | 1.04 | Mlig455_061369 | Neo: - Age: - |
MAN2C1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_061369 {REF} {Length: 4885} {TRANSSPLICED} {Pfam: Glycosyl hydrolases family 38 N-terminal domain [PF01074.24, score=252.5]; Glycosyl hydrolases family 38 C-terminal domain [PF07748.15, score=92.6]; Alpha mannosidase middle domain [PF09261.13, score=67.9]} {Human: ENSG00000140400, MAN2C1, mannosidase alpha class 2C member 1, [RH, Score=611, Expect=0.0]} {Mouse: ENSMUSG00000032295, Man2c1, mannosidase, alpha, class 2C, member 1, [RH, Score=605, Expect=0.0]} {Smed: dd_Smed_v6_7449_0_11, dd_Smed_v6_7449_0_11, [RH, Score=734, Expect=0.0]} {RNA1509_13703} {RNA1310_2504.1, RNA1509_13703} {RNA1509_13703, RNA815_715} |
24. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
0.959 | - | - | - | - | 0.959 | - | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
25. | MligTC455_48186 | 92 | 1.91 | Mlig455_061090 | Neo: - Age: - Region-enriched R4: 3.239/0.03988 |
0.958 | - | - | - | - | - | 0.958 | Mlig455_061090 {REF} {Length: 735} {NoTransDecoderORF} {RNA1310_40260.1} {RNA815_21503} | |
26. | MligTC455_52726 | 213 | 4.44 | Mlig455_032119 | Neo: - Age: - Region-enriched R2: 4.573/0.00005 |
0.958 | - | - | - | - | 0.958 | - | Mlig455_032119 {REF} {Length: 2626} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=61.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=21.0]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=137, Expect=2e-37]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
27. | MligTC455_53895 | 21 | 0.43 | Mlig455_053958 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_053958 {REF} {Length: 208} {NoTransDecoderORF} {RNA1310_28234} {RNA815_49657} | |
28. | MligTC455_01762 | 8 | 0.17 | Mlig455_065032 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_065032 {REF} {Length: 627} {NoTransDecoderORF} {RNA1310_134975} | |
29. | MligTC455_38271 | 28 | 0.58 | Mlig455_007218, Mlig455_007452 | Neo: - Age: - |
NMBR | 0.953 | - | - | - | - | 0.953 | - | Mlig455_007218 {REF} {Length: 2883} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=39.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=29.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.1]} {Human: ENSG00000135577, NMBR, neuromedin B receptor, [Score=109, Expect=7e-26]; ENSG00000182687, GALR2, galanin receptor 2, [Score=109, Expect=7e-26]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=107, Expect=6e-25]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=104, Expect=3e-24]; ENSMUSG00000025905, Oprk1, opioid receptor, kappa 1, [Score=103, Expect=5e-24]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=102, Expect=1e-23]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=101, Expect=4e-23]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=116, Expect=9e-28]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=89.7, Expect=2e-19]} {Smed: dd_Smed_v6_16861_0_1, dd_Smed_v6_16861_0_1, [Score=129, Expect=2e-33]} {RNA1509_59962} {RNA1310_93226} {RNA815_13947} Mlig455_007452 {REF} {Length: 2739} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=39.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=29.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.1]} {Human: ENSG00000135577, NMBR, neuromedin B receptor, [Score=109, Expect=7e-26]; ENSG00000182687, GALR2, galanin receptor 2, [Score=109, Expect=7e-26]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=107, Expect=6e-25]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=104, Expect=3e-24]; ENSMUSG00000025905, Oprk1, opioid receptor, kappa 1, [Score=103, Expect=5e-24]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=102, Expect=1e-23]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=101, Expect=4e-23]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=116, Expect=9e-28]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=89.7, Expect=2e-19]} {Smed: dd_Smed_v6_16861_0_1, dd_Smed_v6_16861_0_1, [Score=129, Expect=2e-33]} {RNA1509_59962} {RNA1310_93226} {RNA815_13947} |
30. | MligTC455_48258 | 34 | 0.71 | Mlig455_020899 | Neo: - Age: Down-Down-Up |
VAV3 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_020899 {REF} {Length: 3371} {Pfam: Calponin homology (CH) domain [PF00307.33, score=42.1]; RhoGEF domain [PF00621.22, score=39.9]; SH2 domain [PF00017.26, score=27.7]; CAMSAP CH domain [PF11971.10, score=19.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=18.8]} {Human: ENSG00000134215, VAV3, vav guanine nucleotide exchange factor 3, [Score=142, Expect=3e-34]; ENSG00000160293, VAV2, vav guanine nucleotide exchange factor 2, [Score=141, Expect=5e-34]} {Mouse: ENSMUSG00000009621, Vav2, vav 2 oncogene, [Score=140, Expect=6e-34]; ENSMUSG00000033721, Vav3, vav 3 oncogene, [Score=139, Expect=1e-33]} {Celegans: WBGene00006887, vav-1, [Score=109, Expect=4e-24]} {Smed: dd_Smed_v6_6109_0_1, dd_Smed_v6_6109_0_1, [Score=96.7, Expect=2e-20]} {RNA1310_24185} {RNA815_29420} |
31. | MligTC455_53957 | 80 | 1.66 | Mlig455_068224 | Neo: - Age: Up-Down-Up |
0.953 | - | - | - | - | 0.953 | - | Mlig455_068224 {REF} {Length: 3283} {RNA1310_18298} {RNA815_25523} | |
32. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
0.952 | - | - | - | - | 0.952 | - | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
33. | MligTC455_42524 | 865 | 18.03 | Mlig455_001409, Mlig455_064268 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_001409 {REF} {Length: 977} {Smed: dd_Smed_v6_391_0_1, dd_Smed_v6_391_0_1, [RH, Score=76.6, Expect=3e-20]} {RNA1509_31794} {RNA1310_45655, RNA1509_31794} {RNA1509_31794, RNA815_25121.1} Mlig455_064268 {REF} {Length: 1019} {Smed: dd_Smed_v6_391_0_1, dd_Smed_v6_391_0_1, [RH, Score=76.6, Expect=3e-20]} {RNA1509_31794} {RNA1310_45655} {RNA815_25121.1} |
|
34. | MligTC455_01654 | 34 | 0.71 | Mlig455_025189 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_025189 {REF} {Length: 577} {NoTransDecoderORF} {RNA1509_16128} {RNA1310_76847} {RNA815_29511.2} | |
35. | MligTC455_57023 | 35 | 0.72 | Mlig455_025177 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_025177 {REF} {Length: 323} {NoTransDecoderORF} {RNA1509_16128} {RNA1310_99479.1} {RNA815_29511.2} | |
36. | MligTC455_17613 | 16 | 0.34 | Mlig455_057846 | Neo: - Age: - |
ADRB2 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_057846 {REF} {Length: 2337} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=166.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=20.3]} {Human: ENSG00000169252, ADRB2, adrenoceptor beta 2, [Score=114, Expect=3e-27]} {Mouse: ENSMUSG00000045730, Adrb2, adrenergic receptor, beta 2, [Score=115, Expect=1e-27]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=126, Expect=3e-31]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=115, Expect=5e-28]} {Smed: dd_Smed_v6_22653_0_1, dd_Smed_v6_22653_0_1, [Score=239, Expect=2e-74]} {RNA1310_68068} {RNA815_49974} |
37. | MligTC455_28739 | 31 | 0.64 | Mlig455_039004 | Neo: - Age: - |
TANC2 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_039004 {REF} {Length: 5623} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=44.5]; Mab-21 protein [PF03281.16, score=43.7]; Ankyrin repeats (3 copies) [PF12796.9, score=42.7]; Ankyrin repeats (many copies) [PF13857.8, score=40.3]; Ankyrin repeat [PF13606.8, score=35.3]; Ankyrin repeat [PF00023.32, score=31.4]} {Human: ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=69.3, Expect=2e-11]; ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=66.2, Expect=3e-10]} {Mouse: ENSMUSG00000053580, Tanc2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=69.3, Expect=2e-11]; ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=67.0, Expect=1e-10]} {Dmel: FBgn0041096, rols, rolling pebbles, [Score=62.8, Expect=1e-09]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=57.4, Expect=5e-08]} {Smed: dd_Smed_v6_12936_0_1, dd_Smed_v6_12936_0_1, [Score=65.1, Expect=2e-10]} {RNA1509_27730} {RNA1310_1764.1} {RNA815_5358.1} |